S&T Bank received the American Bankers Association Marketing Excellence Award for its "S&T Bank Draft Headquarters" campaign during the NFL Draft week in Pittsburgh. The campaign enhanced the bank's brand visibility and community engagement across Western Pennsylvania through a three-day immersive event, media partnerships, and regional outreach. It also included a $50,000 donation to Pennsylvania Wounded Warriors funded by event ticket sales. This recognition highlights S&T Bank's commitment to its community and innovative marketing strategies.
S&T Bank's marketing award is presented here with a snapshot of the Financials sector on Pluang. As of Sep 24, 2026 23:04 WIB, out of 85 priced Financials-sector US stocks, 16 rose while 67 fell. Moody's Corporation traded at USD 464.46 with a 1-day change of -2.00% and a typical hold time of 130 days, contrasting with Affirm Holdings Inc at USD 69.35 which rose 1.85% and had a much shorter typical hold time of 21 days. Deutsche Bank AG was priced at USD 35.25, down 1.73%, with 100% buy order activity on Pluang.
Costco reported a strong Q4 earnings per share (EPS) of $6.75, surpassing analyst expectations of $6.54, helped by tariff refunds. Although quarterly revenue of $93.87 billion slightly missed the $94.97 billion forecast, net sales rose 11.2% year-ove...
Vistry Group reported a significant first-half pre-tax loss of £661.3 million, driven by a £475 million goodwill impairment and increased building safety costs. Revenue fell to £1.42 billion, and operational performance weakened with fewer home compl...
Vail Resorts is set to report its Q3 2026 earnings on September 28, with analysts forecasting a loss per share around -$5.30 and revenue near $271 million, indicating flat performance year-over-year. The company’s financial health shows a high Debt-t...
Western Union faces multiple analyst downgrades with price targets cut to as low as $6.00, reflecting concerns over its profitability and competitive pressures from fintech rivals. The stock has fallen over 15% in the past month, trading near $6.00, ...
Citigroup lowered ACADIA Pharmaceuticals' price target from $40 to $33 after its Alzheimer's drug remlifanserin missed the primary goal in a mid-stage trial, causing a 10.5% stock drop. Despite this, Citigroup kept a "Buy" rating, citing promising se...
